SMG's talks with third party lapse; UOB Kay Hian still rooting for stock
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
HEALTHCARE services provider Singapore Medical Group (SMG) is no longer in talks with a third party regarding a possible transaction involving the company's shares.
But UOB Kay Hian (UOBKH) is still excited about prospects for the stock, noting SMG's "stellar growth prospects" in terms of "organic clinic growth, expansion overseas and telehealth".
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
